FDA Approved: BONJESTA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bonjesta (doxylamine succinate and pyridoxine hydrochloride) submitted by Duchesnay USA, Inc., under NDA 209661.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nausea and Vomiting in Pregnancy

Drugs mentioned

• Bonjesta (doxylamine succinate and pyridoxine hydrochloride)

Snippet

SUPPL AP for BONJESTA (DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE)